Digital Health

Alife Raises a $22M Series A to Modernize and Personalize Fertility Care with AI

Femtch Insider
Now Reading:  
Alife Raises a $22M Series A to Modernize and Personalize Fertility Care with AI

That's so meta - AI in IVF

In this Femtech Insider article, you'll learn about:

  • AI company, Alife's mission to improve IVF

"Alife’s mission is to enhance IVF clinical decision making with personalized, data-driven patient insights, ultimately helping clinicians maximize each patient’s chances of success while lowering costs and barriers to access."

  • Current problems with IVF fertility care

" Today, the 180 million people around the world who struggle with infertility face treatment options that are both expensive and inaccessible. The average IVF cycle can cost up to $25,000 in the U.S., and patients typically go through 3 to 5 cycles to have a baby. Successful pregnancies from IVF rely on a complex set of clinical decisions to deliver the optimal care for each patient. However, there is no unified technology platform working to optimize those decisions and improve the patient experience. "

  • Why investors are keen on supporting this mission

" By building a first-of-its kind modern, diverse dataset, Alife is on track to transform the anachronism of fertility care through advanced AI and intuitive vertical software,” says Deena Shakir, Partner at Lux Capital."


Read the full article here > >
This is some text inside of a div block.

Community Comments